FDA Expected to Decide Soon on First mRNA Flu Vaccine Approval

The U.S. Food and Drug Administration is anticipated to make a decision shortly regarding the approval of the first influenza vaccine utilizing mRNA technology. This potential approval would represent a significant advancement in flu prevention, introducing a new vaccine platform similar to those used for COVID-19.